Day one at APAAC 2018 drew to a close with a discussion regarding the recently issued WHO statement regarding the safety of dolutegravir in pregnancy.
BHIVA statement on Potential Safety Signal in Infants Born to Women Conceiving on Dolutegravir (on behalf of the BHIVA HIV in Pregnancy Guidelines Committee) [22 May 2018]
Privacy | Terms & Conditions | Contact Us | Copyright
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine | ABN 48 264 545 457 | CFN 17788 | Copyright © 2020. ASHM